Screening and isolation of a natural dopamine D1 receptor antagonist using cell-based assays

S Yu, JS Park, V Paredes, MC Song, NI Baek… - Journal of …, 2010 - Elsevier
To develop a cell-based assay to screen for human dopamine D1 receptor agonists or
antagonists from medicinal plant extracts, a stable Chinese hamster ovary (CHO) cell line …

[PDF][PDF] Dopaminergic modulation of learning and memory in the hippocampus and cerebellum

VM Caragea - 2024 - d-nb.info
The gross anatomical properties of the hippocampus and cerebellum structures are
preserved across mammalian species (Amaral and Lavenex 2007; Sillitoe et al. 2005). For …

Target validation using human tissue: from gene expression to function

RA Coleman, KL Clark - Targets, 2003 - Elsevier
Arguably, one of the main reasons for the pharmaceutical industry's current poor
performance in bringing successful new drugs to market is its over-reliance on animal data …

mRNA D2 Dopaminergic Receptor Expression after Hypoxia-Ischemia in Rat Immature Brain

S Cantagrel, P Gressens, S Bodard, AL Suc, J Laugier… - Neonatology, 2001 - karger.com
Previous studies have shown a reduction of dopaminergic D2 receptors (D2R) in the
striatum after hypoxia-ischemia in newborn rats. We show here an early and transient …

[图书][B] Chemical neuroanatomy of the primate brain

DS Melchitzky, MC Austin, DA Lewis - 2004 - books.google.com
O ther chapters in this textbook address the questions of how psychotropic medications
affect the brain to reduce the severity of the clinical features and symptoms of psychiatric …

Neurotransmitter receptor histochemistry: the contribution of in situ hybridization

MT Vilaro, JM Palacios, G Mengod - Life sciences, 1995 - Elsevier
Molecular cloning of neurotransmitter receptors has enabled the application of in situ
hybridization histochemistry to the study of the regional distribution and cellular localization …

Dopamine receptor alternative splicing

NM Richtand, LM Pritchard, LM Coolen - Dopamine and Glutamate in …, 2005 - Springer
The five dopamine receptor subtypes (D1–D5) are members of the superfamily of G protein-
coupled receptors (see also Chapter 1). Dopamine receptors. have been known since 1978 …

In vivo effects of pardoprunox (SLV308), a partial D2/D3 receptor and 5‐HT1A receptor agonist, on rat dopamine and serotonin neuronal activity

C Bétry, A Etiévant, L Lambás‐Señas, AC Mccreary… - Synapse, 2011 - Wiley Online Library
The nonergot ligand pardoprunox (SLV308) is a dopamine (DA) D2/D3 and serotonin (5‐
HT) 1A receptor agonist and a new candidate for the treatment of Parkinson's disease. We …

D3 Receptor Agonists and Antagonists as Anti‐Parkinsonian Therapeutic Agents

M Johnson, A Dutta - 2013 - books.rsc.org
Dopamine (DA) neurons and their associated receptors have long been known to be
implicated in the pathogenesis of Parkinson's disease (PD). The DA receptors …

Receptor localization in the human hypothalamus.

JM Palacios, A Probst, G Mengod - Progress in brain research, 1992 - europepmc.org
In summary, we have illustrated and discussed the applicability of different techniques to the
study of neurotransmitter receptors in the human brain. Because of the availability of these …